PCN68 COST-EFFECTIVENESS OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VERSUS FILGRASTIM FOR THE PREVENTION OF FEBRILE NEUTROPENIA IN NON-HODGKIN LYMPHOMA AND STAGE II BREAST CANCER PATIENTS IN GERMANY
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)71963-5
https://www.valueinhealthjournal.com/article/S1098-3015(11)71963-5/fulltext
Title :
PCN68 COST-EFFECTIVENESS OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VERSUS FILGRASTIM FOR THE PREVENTION OF FEBRILE NEUTROPENIA IN NON-HODGKIN LYMPHOMA AND STAGE II BREAST CANCER PATIENTS IN GERMANY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71963-5&doi=10.1016/S1098-3015(11)71963-5
First page :
A263
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
121